- Home
- CBUS vs ECOR Comparison
CBUS vs ECOR Comparison
Compare CBUS & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CBUS | ECOR |
|---|---|---|
| Founded | 2010 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.5M | 81.0M |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CBUS | ECOR |
|---|---|---|
| Price | $1.79 | $6.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $9.00 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 499.8K | 93.5K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.33 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $3,639,000.00 | ★ $32,032,000.00 |
| Revenue This Year | $112.72 | $33.60 |
| Revenue Next Year | $83.18 | $30.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 27.20 |
| 52 Week Low | $1.09 | $4.16 |
| 52 Week High | $4.19 | $10.50 |
Technical Indicators
Market Signals| Indicator | CBUS | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 54.01 | 40.36 |
| Support Level | $1.31 | $4.64 |
| Resistance Level | $1.99 | $7.17 |
| Average True Range (ATR) | 0.24 | 0.75 |
| MACD | -0.00 | -0.08 |
| Stochastic Oscillator | 37.23 | 18.27 |
Price Performance
Historical ComparisonAbout CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
About ECOR electroCore Inc.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.